Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zikun Wu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Public Health|January 17, 2025
Economic policy uncertainty and corporate innovation-empirical evidence from Chinese pharmaceutical listed companiesZikun Wu, Su Wang, Licong Kuang, et al.
Human Vaccines & Immunotherapeutics|September 22, 2020
Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, ChinaQingfeng Mai, Xiaohan Yang, Huan Cheng, et al.
Frontiers in Public Health|July 22, 2024
The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference modelsXinqing Chen, Shiyi Chen, Zikun Wu, et al.
Frontiers in Oncology|April 29, 2026
The vesicle transport gene SEC23A is a novel prognostic indicator and therapeutic target in gastric cancerLiang Li, Guanglong Chen, Weijie Zhao, et al.
Oncology Reports|December 5, 2025
Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)Wenpu Zhu, Zikun Wu, Chai Luv, et al.
Oncology Reports|April 30, 2026
E3 ubiquitin ligase RNF40: Structure, function and its context‑dependent roles in tumorigenesis (Review)Zikun Wu, Hang Yang, Guanglong Chen, et al.
Genomics|October 2, 2025
Identifying and characterizing a novel APC promoter 1B deletion in a Chinese family with familial adenomatous polyposisHuihan Ai, Hang Yang, Chai Luv, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Public Health|January 17, 2025
Economic policy uncertainty and corporate innovation-empirical evidence from Chinese pharmaceutical listed companiesZikun Wu, Su Wang, Licong Kuang, et al.
Human Vaccines & Immunotherapeutics|September 22, 2020
Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, ChinaQingfeng Mai, Xiaohan Yang, Huan Cheng, et al.
Frontiers in Public Health|July 22, 2024
The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference modelsXinqing Chen, Shiyi Chen, Zikun Wu, et al.
Frontiers in Oncology|April 29, 2026
The vesicle transport gene SEC23A is a novel prognostic indicator and therapeutic target in gastric cancerLiang Li, Guanglong Chen, Weijie Zhao, et al.
Oncology Reports|December 5, 2025
Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)Wenpu Zhu, Zikun Wu, Chai Luv, et al.
Oncology Reports|April 30, 2026
E3 ubiquitin ligase RNF40: Structure, function and its context‑dependent roles in tumorigenesis (Review)Zikun Wu, Hang Yang, Guanglong Chen, et al.
Genomics|October 2, 2025
Identifying and characterizing a novel APC promoter 1B deletion in a Chinese family with familial adenomatous polyposisHuihan Ai, Hang Yang, Chai Luv, et al.
Pageof 1